{"id":"https://openalex.org/W3036726575","doi":"https://doi.org/10.3390/cancers12061663","title":"Molecular Bases of Drug Resistance in Hepatocellular Carcinoma","display_name":"Molecular Bases of Drug Resistance in Hepatocellular Carcinoma","alternate_titles":[],"publication_year":2020,"publication_date":"2020-06-23","ids":{"openalex":"https://openalex.org/W3036726575","doi":"https://doi.org/10.3390/cancers12061663","mag":"3036726575","pmid":"https://pubmed.ncbi.nlm.nih.gov/32585893","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7352164"},"language":"en","primary_location":{"id":"doi:10.3390/cancers12061663","doi":"https://doi.org/10.3390/cancers12061663","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/cancers12061663","pdf_url":"https://www.mdpi.com/2072-6694/12/6/1663/pdf?version=1592905468","source":{"id":"https://openalex.org/S168415115","display_name":"Cancers","issn_l":"2072-6694","issn":["2072-6694"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3036726575"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2072-6694/12/6/1663/pdf?version=1592905468","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005462346","display_name":"Jos\u00e9 J.G. Mar\u00edn","orcid":"https://orcid.org/0000-0003-1186-6849","observed_orcids":["https://orcid.org/0000-0003-1186-6849"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210132431","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","ror":"https://ror.org/03cn6tr16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210132431"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Jose J.G. Marin","raw_affiliation_strings":["Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain","Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain"],"raw_orcid":"https://orcid.org/0000-0003-1186-6849","affiliations":[{"raw_affiliation_string":"Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210132431"]},{"raw_affiliation_string":"Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050790248","display_name":"Roc\u00edo I.R. Mac\u00edas","orcid":"https://orcid.org/0000-0002-4748-0326","observed_orcids":["https://orcid.org/0000-0002-4748-0326"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210132431","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","ror":"https://ror.org/03cn6tr16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210132431"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rocio I.R. Macias","raw_affiliation_strings":["Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain","Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain"],"raw_orcid":"https://orcid.org/0000-0002-4748-0326","affiliations":[{"raw_affiliation_string":"Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210132431"]},{"raw_affiliation_string":"Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048595371","display_name":"Mar\u00eda Jes\u00fas Monte","orcid":"https://orcid.org/0000-0003-1844-7428","observed_orcids":["https://orcid.org/0000-0003-1844-7428"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210132431","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","ror":"https://ror.org/03cn6tr16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210132431"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria J. Monte","raw_affiliation_strings":["Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain","Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain"],"raw_orcid":"https://orcid.org/0000-0003-1844-7428","affiliations":[{"raw_affiliation_string":"Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210132431"]},{"raw_affiliation_string":"Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021872552","display_name":"Marta R. Romero","orcid":"https://orcid.org/0000-0001-6729-0215","observed_orcids":["https://orcid.org/0000-0001-6729-0215"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210132431","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","ror":"https://ror.org/03cn6tr16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210132431"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marta R. Romero","raw_affiliation_strings":["Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain","Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210132431"]},{"raw_affiliation_string":"Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064346125","display_name":"Maitane Asensio","orcid":"https://orcid.org/0000-0002-8723-6053","observed_orcids":["https://orcid.org/0000-0002-8723-6053"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maitane Asensio","raw_affiliation_strings":["Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060425529","display_name":"Anabel S\u00e1nchez-Mart\u00edn","orcid":"https://orcid.org/0000-0003-1577-2110","observed_orcids":["https://orcid.org/0000-0003-1577-2110"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Anabel Sanchez-Martin","raw_affiliation_strings":["Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009708120","display_name":"Candela Cives-Losada","orcid":"https://orcid.org/0000-0003-0430-838X","observed_orcids":["https://orcid.org/0000-0003-0430-838X"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Candela Cives-Losada","raw_affiliation_strings":["Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005837150","display_name":"\u00c1lvaro G. Temprano","orcid":"https://orcid.org/0000-0002-5478-5937","observed_orcids":["https://orcid.org/0000-0002-5478-5937"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alvaro G. Temprano","raw_affiliation_strings":["Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026869228","display_name":"Ricardo A. Espinosa-Escudero","orcid":"https://orcid.org/0000-0002-4811-8230","observed_orcids":["https://orcid.org/0000-0002-4811-8230"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ricardo Espinosa-Escudero","raw_affiliation_strings":["Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061081366","display_name":"Mar\u00eda Reviejo","orcid":"https://orcid.org/0000-0001-8476-5489","observed_orcids":["https://orcid.org/0000-0001-8476-5489"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Reviejo","raw_affiliation_strings":["Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011332674","display_name":"Laura H Boh\u00f3rquez","orcid":"https://orcid.org/0009-0004-9085-9499","observed_orcids":["https://orcid.org/0009-0004-9085-9499"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laura H. Bohorquez","raw_affiliation_strings":["Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044490536","display_name":"\u00d3scar Briz","orcid":"https://orcid.org/0000-0001-6891-1554","observed_orcids":["https://orcid.org/0000-0001-6891-1554"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210132431","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","ror":"https://ror.org/03cn6tr16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210132431"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Oscar Briz","raw_affiliation_strings":["Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain","Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain"],"raw_orcid":"https://orcid.org/0000-0001-6891-1554","affiliations":[{"raw_affiliation_string":"Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210132431"]},{"raw_affiliation_string":"Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, IBSAL, 37007 Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5005462346","https://openalex.org/A5044490536"],"corresponding_institution_ids":["https://openalex.org/I184999862","https://openalex.org/I2801357902","https://openalex.org/I4210132431","https://openalex.org/I4210134045"],"apc_list":{"value":2200,"currency":"CHF","value_usd":2324},"apc_paid":{"value":2200,"currency":"CHF","value_usd":2324},"fwci":3.1265,"has_fulltext":true,"cited_by_count":223,"citation_normalized_percentile":{"value":0.94645941,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"12","issue":"6","first_page":"1663","last_page":"1663"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.753000020980835},{"id":"https://openalex.org/keywords/chemoresistance-mechanisms","display_name":"chemoresistance mechanisms","score":0.7950000166893005},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/regorafenib","display_name":"regorafenib","score":1.0},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6869999766349792},{"id":"https://openalex.org/keywords/druggable-targets","display_name":"druggable targets","score":0.8460000157356262},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7120000123977661}],"concepts":[{"id":"https://openalex.org/C2776248978","wikidata":"https://www.wikidata.org/wiki/Q3891664","display_name":"Regorafenib","level":4,"score":0.9421632289886475},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.8892337083816528},{"id":"https://openalex.org/C10679952","wikidata":"https://www.wikidata.org/wiki/Q5308937","display_name":"Druggability","level":3,"score":0.8365668058395386},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7879420518875122},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7528514266014099},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5523866415023804},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4696005582809448},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.45252788066864014},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41015443205833435},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40990597009658813},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3932091295719147},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38143354654312134},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33219003677368164},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.16980788111686707},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1626814305782318},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15445497632026672},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3390/cancers12061663","doi":"https://doi.org/10.3390/cancers12061663","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/cancers12061663","pdf_url":"https://www.mdpi.com/2072-6694/12/6/1663/pdf?version=1592905468","source":{"id":"https://openalex.org/S168415115","display_name":"Cancers","issn_l":"2072-6694","issn":["2072-6694"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"journal-article"},{"id":"pmid:32585893","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32585893","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7352164","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7352164/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers (Basel)","raw_type":"Text"},{"id":"pmh:oai:zenodo.org:18819213","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.3390/cancers12061663","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/review"}],"best_oa_location":{"id":"doi:10.3390/cancers12061663","doi":"https://doi.org/10.3390/cancers12061663","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/cancers12061663","pdf_url":"https://www.mdpi.com/2072-6694/12/6/1663/pdf?version=1592905468","source":{"id":"https://openalex.org/S168415115","display_name":"Cancers","issn_l":"2072-6694","issn":["2072-6694"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G212836150","display_name":null,"funder_award_id":"SA063P17","funder_id":"https://openalex.org/F4320328351","funder_display_name":"Junta de Castilla y Le\u00f3n"},{"id":"https://openalex.org/G2687729442","display_name":"Quimiorresistencia del adenocarcinoma g\u00e1strico: Caracterizaci\u00f3n de su huella gen\u00e9tica y superaci\u00f3n mediante edici\u00f3n gen\u00f3mica programada basada en CRISPR/Cas9.","funder_award_id":"PI16/00598","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G2973466802","display_name":null,"funder_award_id":"2017/2020","funder_id":"https://openalex.org/F4320321411","funder_display_name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer"},{"id":"https://openalex.org/G3293287054","display_name":null,"funder_award_id":"EHD15PI05/2016","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G4226265948","display_name":null,"funder_award_id":"EDU/574/2018","funder_id":"https://openalex.org/F4320328351","funder_display_name":"Junta de Castilla y Le\u00f3n"},{"id":"https://openalex.org/G5382326010","display_name":null,"funder_award_id":"SAF2016-75197-R","funder_id":"https://openalex.org/F4320326262","funder_display_name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a"},{"id":"https://openalex.org/G6389441387","display_name":null,"funder_award_id":"EDU/574/2018","funder_id":"https://openalex.org/F4320338080","funder_display_name":"European Social Fund"},{"id":"https://openalex.org/G7159902924","display_name":"Inter\u00e9s pron\u00f3stico y terap\u00e9utico de las prote\u00ednas SLC y ABC en adenocarcinomas hep\u00e1ticos y gastrointestinales","funder_award_id":"PI19/00819","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G7505454962","display_name":null,"funder_award_id":"EHD15PI05/2016","funder_id":"https://openalex.org/F4320329144","funder_display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas"},{"id":"https://openalex.org/G814523509","display_name":null,"funder_award_id":"SA063P17","funder_id":"https://openalex.org/F4320325114","funder_display_name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n"},{"id":"https://openalex.org/G8289202400","display_name":null,"funder_award_id":"/00598","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"}],"funders":[{"id":"https://openalex.org/F4320315062","display_name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","ror":null},{"id":"https://openalex.org/F4320321411","display_name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","ror":"https://ror.org/00gxct719"},{"id":"https://openalex.org/F4320325114","display_name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","ror":"https://ror.org/02s8dab97"},{"id":"https://openalex.org/F4320326262","display_name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","ror":"https://ror.org/03sv46s19"},{"id":"https://openalex.org/F4320328351","display_name":"Junta de Castilla y Le\u00f3n","ror":"https://ror.org/02s8dab97"},{"id":"https://openalex.org/F4320329144","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","ror":"https://ror.org/03cn6tr16"},{"id":"https://openalex.org/F4320334923","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886"},{"id":"https://openalex.org/F4320335322","display_name":"European Regional Development Fund","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320338080","display_name":"European Social Fund","ror":"https://ror.org/00k4n6c32"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3036726575.pdf","grobid_xml":"https://content.openalex.org/works/W3036726575.grobid-xml"},"referenced_works_count":199,"referenced_works":["https://openalex.org/W1126019608","https://openalex.org/W1174667314","https://openalex.org/W1447747419","https://openalex.org/W1551157466","https://openalex.org/W1732509072","https://openalex.org/W1834150740","https://openalex.org/W1901686572","https://openalex.org/W1963483543","https://openalex.org/W1974741877","https://openalex.org/W1984500423","https://openalex.org/W1989056960","https://openalex.org/W1994578837","https://openalex.org/W1995221950","https://openalex.org/W1997533142","https://openalex.org/W1997567636","https://openalex.org/W2003938487","https://openalex.org/W2010631759","https://openalex.org/W2010653264","https://openalex.org/W2012912125","https://openalex.org/W2014790162","https://openalex.org/W2016828736","https://openalex.org/W2019224185","https://openalex.org/W2019386246","https://openalex.org/W2019464570","https://openalex.org/W2023815439","https://openalex.org/W2024432674","https://openalex.org/W2025804674","https://openalex.org/W2028896157","https://openalex.org/W2030764098","https://openalex.org/W2034846190","https://openalex.org/W2036073268","https://openalex.org/W2037440964","https://openalex.org/W2037527490","https://openalex.org/W2038464222","https://openalex.org/W2039456155","https://openalex.org/W2041259862","https://openalex.org/W2045336712","https://openalex.org/W2045796389","https://openalex.org/W2047544514","https://openalex.org/W2047770640","https://openalex.org/W2049643670","https://openalex.org/W2054421320","https://openalex.org/W2055275875","https://openalex.org/W2055294608","https://openalex.org/W2055528768","https://openalex.org/W2055819290","https://openalex.org/W2063488708","https://openalex.org/W2067232729","https://openalex.org/W2068424305","https://openalex.org/W2075093463","https://openalex.org/W2075168918","https://openalex.org/W2083479805","https://openalex.org/W2093538839","https://openalex.org/W2094751839","https://openalex.org/W2096201751","https://openalex.org/W2099709490","https://openalex.org/W2101791772","https://openalex.org/W2104072969","https://openalex.org/W2104271563","https://openalex.org/W2105396478","https://openalex.org/W2111070218","https://openalex.org/W2112245889","https://openalex.org/W2114994872","https://openalex.org/W2117348043","https://openalex.org/W2123546830","https://openalex.org/W2124006359","https://openalex.org/W2124427232","https://openalex.org/W2128153851","https://openalex.org/W2137672147","https://openalex.org/W2139504369","https://openalex.org/W2139622109","https://openalex.org/W2144269285","https://openalex.org/W2147748185","https://openalex.org/W2155397673","https://openalex.org/W2155430191","https://openalex.org/W2157975224","https://openalex.org/W2158535498","https://openalex.org/W2159789129","https://openalex.org/W2161428444","https://openalex.org/W2162242700","https://openalex.org/W2163724251","https://openalex.org/W2168381076","https://openalex.org/W2168472139","https://openalex.org/W2170845559","https://openalex.org/W2177575632","https://openalex.org/W2182157953","https://openalex.org/W2185397807","https://openalex.org/W2198606871","https://openalex.org/W2281908831","https://openalex.org/W2283284501","https://openalex.org/W2310576747","https://openalex.org/W2407477249","https://openalex.org/W2407812106","https://openalex.org/W2412696100","https://openalex.org/W2412731081","https://openalex.org/W2413575764","https://openalex.org/W2473463734","https://openalex.org/W2511144966","https://openalex.org/W2516755388","https://openalex.org/W2520809168","https://openalex.org/W2523767931","https://openalex.org/W2529896336","https://openalex.org/W2554580968","https://openalex.org/W2555216255","https://openalex.org/W2556648133","https://openalex.org/W2560367415","https://openalex.org/W2566736848","https://openalex.org/W2567935285","https://openalex.org/W2569798134","https://openalex.org/W2569886419","https://openalex.org/W2570752112","https://openalex.org/W2574465504","https://openalex.org/W2583669482","https://openalex.org/W2596609243","https://openalex.org/W2606367731","https://openalex.org/W2607127660","https://openalex.org/W2612428976","https://openalex.org/W2616126806","https://openalex.org/W2618532496","https://openalex.org/W2740085700","https://openalex.org/W2741471290","https://openalex.org/W2744882241","https://openalex.org/W2748697430","https://openalex.org/W2751649521","https://openalex.org/W2756602348","https://openalex.org/W2764020274","https://openalex.org/W2766201623","https://openalex.org/W2766324863","https://openalex.org/W2768386770","https://openalex.org/W2770519623","https://openalex.org/W2782986228","https://openalex.org/W2789881042","https://openalex.org/W2790328300","https://openalex.org/W2794466912","https://openalex.org/W2797771850","https://openalex.org/W2805076614","https://openalex.org/W2805521969","https://openalex.org/W2805592007","https://openalex.org/W2808399951","https://openalex.org/W2888835964","https://openalex.org/W2892196248","https://openalex.org/W2895926103","https://openalex.org/W2897214576","https://openalex.org/W2898318394","https://openalex.org/W2898606030","https://openalex.org/W2899710363","https://openalex.org/W2900429954","https://openalex.org/W2900958958","https://openalex.org/W2903026114","https://openalex.org/W2905651843","https://openalex.org/W2905892207","https://openalex.org/W2906095458","https://openalex.org/W2906979532","https://openalex.org/W2907105629","https://openalex.org/W2907978256","https://openalex.org/W2914676498","https://openalex.org/W2917573998","https://openalex.org/W2922443161","https://openalex.org/W2922624344","https://openalex.org/W2923934428","https://openalex.org/W2932470287","https://openalex.org/W2933549012","https://openalex.org/W2936407465","https://openalex.org/W2942698941","https://openalex.org/W2943126465","https://openalex.org/W2943333115","https://openalex.org/W2945534893","https://openalex.org/W2950289294","https://openalex.org/W2955734612","https://openalex.org/W2959756457","https://openalex.org/W2962221292","https://openalex.org/W2964450000","https://openalex.org/W2965158060","https://openalex.org/W2968402683","https://openalex.org/W2970394526","https://openalex.org/W2975514178","https://openalex.org/W2975662973","https://openalex.org/W2976498648","https://openalex.org/W2985561106","https://openalex.org/W2990361782","https://openalex.org/W3002683936","https://openalex.org/W3004008945","https://openalex.org/W3004424580","https://openalex.org/W3004965837","https://openalex.org/W3005429361","https://openalex.org/W3008957256","https://openalex.org/W3010295291","https://openalex.org/W3013409109","https://openalex.org/W3022618950","https://openalex.org/W6627365568","https://openalex.org/W6627729443","https://openalex.org/W6654128204","https://openalex.org/W6660373319","https://openalex.org/W6713986194","https://openalex.org/W6715543838","https://openalex.org/W6715691189","https://openalex.org/W6762196475","https://openalex.org/W6773171138","https://openalex.org/W7073856514"],"related_works":["https://openalex.org/W3016912720","https://openalex.org/W2789881042","https://openalex.org/W3200713196","https://openalex.org/W2735215140","https://openalex.org/W4220789684","https://openalex.org/W3186767943","https://openalex.org/W4319990170","https://openalex.org/W2027402570","https://openalex.org/W2804463612","https://openalex.org/W2020002352"],"abstract_inverted_index":{"The":[0,65],"poor":[1],"outcome":[2],"of":[3,16,27,41,43,57,71,78,82,84,94,111,132,148],"patients":[4],"with":[5,87],"non-surgically":[6],"removable":[7],"advanced":[8],"hepatocellular":[9],"carcinoma":[10],"(HCC),":[11],"the":[12,24,39,58,72,79,92,112,130,146],"most":[13],"frequent":[14],"type":[15],"primary":[17],"liver":[18],"cancer,":[19],"is":[20,68],"mainly":[21,47],"due":[22],"to":[23,31,96,128,139,150],"high":[25],"refractoriness":[26],"this":[28],"aggressive":[29],"tumor":[30],"classical":[32,102],"chemotherapy.":[33],"Novel":[34],"pharmacological":[35,98,151],"approaches":[36],"based":[37],"on":[38,91],"use":[40],"inhibitors":[42],"tyrosine":[44],"kinases":[45],"(TKIs),":[46],"sorafenib":[48],"and":[49,106],"regorafenib,":[50],"have":[51,122],"provided":[52],"only":[53],"a":[54,88],"modest":[55],"prolongation":[56],"overall":[59],"survival":[60],"in":[61,119],"these":[62],"HCC":[63,95,149],"patients.":[64],"present":[66],"review":[67],"an":[69],"update":[70],"available":[73],"information":[74],"regarding":[75],"our":[76],"understanding":[77],"molecular":[80],"bases":[81],"mechanisms":[83],"chemoresistance":[85],"(MOC)":[86],"significant":[89],"impact":[90],"response":[93],"existing":[97],"tools,":[99],"which":[100],"include":[101],"chemotherapeutic":[103],"agents,":[104],"TKIs":[105],"novel":[107,141],"immune-sensitizing":[108],"strategies.":[109],"Many":[110],"more":[113],"than":[114],"one":[115],"hundred":[116],"genes":[117],"involved":[118],"seven":[120],"MOC":[121],"been":[123],"identified":[124],"as":[125,134,136],"potential":[126],"biomarkers":[127],"predict":[129],"failure":[131],"treatment,":[133],"well":[135],"druggable":[137],"targets":[138],"develop":[140],"strategies":[142],"aimed":[143],"at":[144],"increasing":[145],"sensitivity":[147],"treatments.":[152]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3036726575","counts_by_year":[{"year":2026,"cited_by_count":31},{"year":2025,"cited_by_count":35},{"year":2024,"cited_by_count":37},{"year":2023,"cited_by_count":44},{"year":2022,"cited_by_count":42},{"year":2021,"cited_by_count":27},{"year":2020,"cited_by_count":7}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2020-06-25T00:00:00"}
